AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
BT is looking for solutions across fintech, defense and future networks.
The 2026 MIT Enterprise AI Forum will spotlight cutting‑edge Enterprise AI strategies, practical frameworks, and breakthrough applications across mission‑critical domains such as real-time digital twins, automated defect detection, and intelligent product lifecycle management.
Hyundai Mobis seeks startups for partnerships around healthcare technologies:
FM Global looking to develop custom briefing on Robotics to manage risks in industrial settings.
Denka, a leading medium-sized chemical manufacturer, is looking for startups that have the technology to visually detect food freshness and spoilage.
The Dubai Police is offering a partnership opportunity for the Smart City Naif project in Dubai. This concept revolves around the deployment of stable sensor networks for pedestrian movement detection, a comprehensive multimodal traffic overview system (car, pedestrian, bike), real-time incident detection, and Al based automated patrol alerts. Additionally, a physical and digital augmented 3D model will provide an interactive platform for decision-making at Naif police station.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.